25 XP   0   0   10

Polynovo Ltd
Buy, Hold or Sell?

Let's analyse Polynovo together

PenkeI guess you are interested in Polynovo Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Polynovo Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Polynovo Ltd

I send you an email if I find something interesting about Polynovo Ltd.

Quick analysis of Polynovo (30 sec.)










What can you expect buying and holding a share of Polynovo? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.09
Expected worth in 1 year
A$0.37
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$0.28
Return On Investment
13.0%

For what price can you sell your share?

Current Price per Share
A$2.13
Expected price per share
A$1.815 - A$2.71
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Polynovo (5 min.)




Live pricePrice per Share (EOD)

A$2.13

Intrinsic Value Per Share

A$-0.10 - A$-0.03

Total Value Per Share

A$-0.01 - A$0.06

2. Growth of Polynovo (5 min.)




Is Polynovo growing?

Current yearPrevious yearGrowGrow %
How rich?$42.7m$11.5m$31.1m72.9%

How much money is Polynovo making?

Current yearPrevious yearGrowGrow %
Making money-$3.2m-$779.7k-$2.4m-75.8%
Net Profit Margin-7.5%-2.9%--

How much money comes from the company's main activities?

3. Financial Health of Polynovo (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#157 / 345

Most Revenue
#83 / 345

Most Profit
#231 / 345

Most Efficient
#151 / 345
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Polynovo? (5 min.)

Welcome investor! Polynovo's management wants to use your money to grow the business. In return you get a share of Polynovo.

What can you expect buying and holding a share of Polynovo?

First you should know what it really means to hold a share of Polynovo. And how you can make/lose money.

Speculation

The Price per Share of Polynovo is A$2.13. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Polynovo.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Polynovo, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.09. Based on the TTM, the Book Value Change Per Share is A$0.07 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Polynovo.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-0.2%0.00-0.2%0.00-0.1%0.00-0.2%0.00-0.2%
Usd Book Value Change Per Share0.052.1%0.052.1%0.00-0.2%0.010.3%0.010.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.052.1%0.052.1%0.00-0.2%0.010.3%0.010.3%
Usd Price Per Share1.01-1.01-0.89-1.28-0.72-
Price to Earnings Ratio-216.55--216.55--784.27--434.96--240.10-
Price-to-Total Gains Ratio22.37-22.37--201.70--545.90--268.07-
Price to Book Ratio16.31-16.31-52.79-54.11-32.65-
Price-to-Total Gains Ratio22.37-22.37--201.70--545.90--268.07-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.392807
Number of shares717
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.01
Usd Total Gains Per Share0.050.01
Gains per Quarter (717 shares)32.385.02
Gains per Year (717 shares)129.5220.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1013012002010
2025925004030
3038938006050
4051851008070
50648640010090
607777700120110
709079000140130
80103610300161150
90116611600181170
100129512900201190

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.024.01.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%4.06.00.040.0%10.015.00.040.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.025.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%4.06.00.040.0%10.015.00.040.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Polynovo

About Polynovo Ltd

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell Implant to host pancreatic islet cells in the skin; NovoSorb MTX for the treatment of varying complex wounds; and plastics and reconstructive device product. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-02-19 15:45:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Polynovo Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Polynovo earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Polynovo to the Medical Devices industry mean.
  • A Net Profit Margin of -7.5% means that $-0.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Polynovo Ltd:

  • The MRQ is -7.5%. The company is making a loss. -1
  • The TTM is -7.5%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-7.5%TTM-7.5%0.0%
TTM-7.5%YOY-2.9%-4.7%
TTM-7.5%5Y-11.8%+4.2%
5Y-11.8%10Y-4,911.3%+4,899.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.5%-11.1%+3.6%
TTM-7.5%-16.4%+8.9%
YOY-2.9%-13.0%+10.1%
5Y-11.8%-18.9%+7.1%
10Y-4,911.3%-22.4%-4,888.9%
1.1.2. Return on Assets

Shows how efficient Polynovo is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Polynovo to the Medical Devices industry mean.
  • -5.3% Return on Assets means that Polynovo generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Polynovo Ltd:

  • The MRQ is -5.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.3%TTM-5.3%0.0%
TTM-5.3%YOY-3.4%-1.9%
TTM-5.3%5Y-7.6%+2.3%
5Y-7.6%10Y-16.6%+9.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.3%-3.5%-1.8%
TTM-5.3%-4.3%-1.0%
YOY-3.4%-3.5%+0.1%
5Y-7.6%-3.8%-3.8%
10Y-16.6%-4.3%-12.3%
1.1.3. Return on Equity

Shows how efficient Polynovo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Polynovo to the Medical Devices industry mean.
  • -7.5% Return on Equity means Polynovo generated $-0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Polynovo Ltd:

  • The MRQ is -7.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.5%TTM-7.5%0.0%
TTM-7.5%YOY-6.7%-0.8%
TTM-7.5%5Y-11.9%+4.4%
5Y-11.9%10Y-19.8%+7.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.5%-3.7%-3.8%
TTM-7.5%-4.9%-2.6%
YOY-6.7%-4.0%-2.7%
5Y-11.9%-5.4%-6.5%
10Y-19.8%-6.1%-13.7%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Polynovo Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Polynovo is operating .

  • Measures how much profit Polynovo makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Polynovo to the Medical Devices industry mean.
  • An Operating Margin of -7.3% means the company generated $-0.07  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Polynovo Ltd:

  • The MRQ is -7.3%. The company is operating very inefficient. -2
  • The TTM is -7.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-7.3%TTM-7.3%0.0%
TTM-7.3%YOY1.3%-8.6%
TTM-7.3%5Y-14.7%+7.4%
5Y-14.7%10Y-13,945.2%+13,930.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.3%-30.8%+23.5%
TTM-7.3%-13.1%+5.8%
YOY1.3%-11.4%+12.7%
5Y-14.7%-19.5%+4.8%
10Y-13,945.2%-24.8%-13,920.4%
1.2.2. Operating Ratio

Measures how efficient Polynovo is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.09 means that the operating costs are $1.09 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Polynovo Ltd:

  • The MRQ is 1.095. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.095. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.095TTM1.0950.000
TTM1.095YOY1.006+0.089
TTM1.0955Y1.148-0.053
5Y1.14810Y148.831-147.683
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0951.453-0.358
TTM1.0951.452-0.357
YOY1.0061.446-0.440
5Y1.1481.464-0.316
10Y148.8311.379+147.452
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Polynovo Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Polynovo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 5.32 means the company has $5.32 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Polynovo Ltd:

  • The MRQ is 5.317. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.317. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.317TTM5.3170.000
TTM5.317YOY2.087+3.230
TTM5.3175Y4.192+1.125
5Y4.19210Y8.795-4.603
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3172.906+2.411
TTM5.3172.888+2.429
YOY2.0873.742-1.655
5Y4.1923.647+0.545
10Y8.7953.546+5.249
1.3.2. Quick Ratio

Measures if Polynovo is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Polynovo to the Medical Devices industry mean.
  • A Quick Ratio of 4.79 means the company can pay off $4.79 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Polynovo Ltd:

  • The MRQ is 4.787. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.787. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.787TTM4.7870.000
TTM4.787YOY1.585+3.202
TTM4.7875Y3.637+1.150
5Y3.63710Y8.344-4.707
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7871.630+3.157
TTM4.7871.654+3.133
YOY1.5852.190-0.605
5Y3.6372.275+1.362
10Y8.3442.259+6.085
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Polynovo Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Polynovo assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Polynovo to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.29 means that Polynovo assets are financed with 29.4% credit (debt) and the remaining percentage (100% - 29.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Polynovo Ltd:

  • The MRQ is 0.294. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.294. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.294TTM0.2940.000
TTM0.294YOY0.493-0.199
TTM0.2945Y0.330-0.036
5Y0.33010Y0.203+0.128
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2940.373-0.079
TTM0.2940.383-0.089
YOY0.4930.329+0.164
5Y0.3300.442-0.112
10Y0.2030.464-0.261
1.4.2. Debt to Equity Ratio

Measures if Polynovo is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Polynovo to the Medical Devices industry mean.
  • A Debt to Equity ratio of 41.7% means that company has $0.42 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Polynovo Ltd:

  • The MRQ is 0.417. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.417. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.417TTM0.4170.000
TTM0.417YOY0.974-0.558
TTM0.4175Y0.555-0.139
5Y0.55510Y0.318+0.237
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4170.526-0.109
TTM0.4170.548-0.131
YOY0.9740.462+0.512
5Y0.5550.617-0.062
10Y0.3180.699-0.381
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Polynovo Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Polynovo generates.

  • Above 15 is considered overpriced but always compare Polynovo to the Medical Devices industry mean.
  • A PE ratio of -216.55 means the investor is paying $-216.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Polynovo Ltd:

  • The EOD is -298.545. Based on the earnings, the company is expensive. -2
  • The MRQ is -216.550. Based on the earnings, the company is expensive. -2
  • The TTM is -216.550. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-298.545MRQ-216.550-81.995
MRQ-216.550TTM-216.5500.000
TTM-216.550YOY-784.269+567.719
TTM-216.5505Y-434.955+218.405
5Y-434.95510Y-240.104-194.851
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-298.545-1.178-297.367
MRQ-216.550-1.550-215.000
TTM-216.550-2.357-214.193
YOY-784.269-2.560-781.709
5Y-434.955-2.140-432.815
10Y-240.104-1.824-238.280
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Polynovo Ltd:

  • The EOD is -180.597. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -130.996. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -130.996. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-180.597MRQ-130.996-49.601
MRQ-130.996TTM-130.9960.000
TTM-130.996YOY-366.920+235.924
TTM-130.9965Y-260.733+129.737
5Y-260.73310Y-148.080-112.653
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-180.597-1.826-178.771
MRQ-130.996-2.414-128.582
TTM-130.996-3.912-127.084
YOY-366.920-6.151-360.769
5Y-260.733-5.283-255.450
10Y-148.080-5.743-142.337
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Polynovo is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 16.31 means the investor is paying $16.31 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Polynovo Ltd:

  • The EOD is 22.486. Based on the equity, the company is expensive. -2
  • The MRQ is 16.310. Based on the equity, the company is expensive. -2
  • The TTM is 16.310. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD22.486MRQ16.310+6.176
MRQ16.310TTM16.3100.000
TTM16.310YOY52.795-36.485
TTM16.3105Y54.108-37.798
5Y54.10810Y32.647+21.461
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD22.4862.161+20.325
MRQ16.3102.382+13.928
TTM16.3102.551+13.759
YOY52.7953.248+49.547
5Y54.1083.863+50.245
10Y32.6474.231+28.416
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Polynovo Ltd.

3.1. Funds holding Polynovo Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2020-10-31Vanguard International Stock Index-Total Intl Stock Indx1.4099999-9342937--
2020-12-31Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund0.56-3735528--
2021-02-28iShares Core MSCI EAFE ETF0.47999998-3161650--
2021-02-28iShares MSCI EAFE Small Cap ETF0.37-2452907--
2020-10-31Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index0.22-1475300--
2020-11-30Schwab Strategic Tr-Schwab International Small Cap Equity ETF0.11999999-812824--
2021-02-28iShares Core MSCI Total International Stock ETF0.1-677246--
2021-02-28SPDR Portfolio Developed World ex-US ETF0.1-639132--
2021-01-31Vanguard International Stock Index-Pacific Stock Index0.090000004-593403--
2020-12-31College Retirement Equities Fund-Stock Account0.090000004-590586--
Total 3.53999987802348151300.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Polynovo Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0690.0690%-0.007+110%0.011+545%0.008+728%
Book Value Per Share--0.0950.0950%0.026+269%0.045+110%0.033+190%
Current Ratio--5.3175.3170%2.087+155%4.192+27%8.795-40%
Debt To Asset Ratio--0.2940.2940%0.493-40%0.330-11%0.203+45%
Debt To Equity Ratio--0.4170.4170%0.974-57%0.555-25%0.318+31%
Dividend Per Share----0%-0%-0%-0%
Eps---0.007-0.0070%-0.002-76%-0.005-26%-0.005-26%
Free Cash Flow Per Share---0.012-0.0120%-0.004-69%-0.010-17%-0.008-31%
Free Cash Flow To Equity Per Share--0.0580.0580%-0.011+120%0.005+1082%0.006+817%
Gross Profit Margin--1.4791.4790%2.057-28%1.471+0%1.324+12%
Intrinsic Value_10Y_max---0.035--------
Intrinsic Value_10Y_min---0.103--------
Intrinsic Value_1Y_max---0.006--------
Intrinsic Value_1Y_min---0.010--------
Intrinsic Value_3Y_max---0.017--------
Intrinsic Value_3Y_min---0.031--------
Intrinsic Value_5Y_max---0.025--------
Intrinsic Value_5Y_min---0.051--------
Market Cap1470196341.120+27%1066410022.0801066410022.0800%935265747.520+14%1352856727.040-21%760636792.448+40%
Net Profit Margin---0.075-0.0750%-0.029-62%-0.118+56%-49.113+64966%
Operating Margin---0.073-0.0730%0.013-658%-0.147+102%-139.452+191559%
Operating Ratio--1.0951.0950%1.006+9%1.148-5%148.831-99%
Pb Ratio22.486+27%16.31016.3100%52.795-69%54.108-70%32.647-50%
Pe Ratio-298.545-38%-216.550-216.5500%-784.269+262%-434.955+101%-240.104+11%
Price Per Share2.130+27%1.5451.5450%1.355+14%1.960-21%1.102+40%
Price To Free Cash Flow Ratio-180.597-38%-130.996-130.9960%-366.920+180%-260.733+99%-148.080+13%
Price To Total Gains Ratio30.842+27%22.37222.3720%-201.698+1002%-545.895+2540%-268.071+1298%
Quick Ratio--4.7874.7870%1.585+202%3.637+32%8.344-43%
Return On Assets---0.053-0.0530%-0.034-36%-0.076+44%-0.166+212%
Return On Equity---0.075-0.0750%-0.067-11%-0.119+58%-0.198+163%
Total Gains Per Share--0.0690.0690%-0.007+110%0.011+545%0.008+728%
Usd Book Value--42754036.55442754036.5540%11583894.735+269%20318213.065+110%14765497.170+190%
Usd Book Value Change Per Share--0.0450.0450%-0.004+110%0.007+545%0.005+728%
Usd Book Value Per Share--0.0620.0620%0.017+269%0.029+110%0.021+190%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.005-0.0050%-0.001-76%-0.003-26%-0.003-26%
Usd Free Cash Flow---5323241.002-5323241.0020%-1666766.252-69%-4406649.886-17%-3653427.053-31%
Usd Free Cash Flow Per Share---0.008-0.0080%-0.002-69%-0.006-17%-0.005-31%
Usd Free Cash Flow To Equity Per Share--0.0380.0380%-0.008+120%0.003+1082%0.004+817%
Usd Market Cap961361387.458+27%697325513.438697325513.4380%611570272.303+14%884633013.811-21%497380398.582+40%
Usd Price Per Share1.393+27%1.0101.0100%0.886+14%1.282-21%0.721+40%
Usd Profit---3220156.052-3220156.0520%-779796.675-76%-2188186.504-32%-2289477.707-29%
Usd Revenue--42661396.57942661396.5790%27097510.722+57%22408443.519+90%12032581.037+255%
Usd Total Gains Per Share--0.0450.0450%-0.004+110%0.007+545%0.005+728%
 EOD+6 -2MRQTTM+0 -0YOY+19 -155Y+23 -1110Y+21 -13

4.2. Fundamental Score

Let's check the fundamental score of Polynovo Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-298.545
Price to Book Ratio (EOD)Between0-122.486
Net Profit Margin (MRQ)Greater than0-0.075
Operating Margin (MRQ)Greater than0-0.073
Quick Ratio (MRQ)Greater than14.787
Current Ratio (MRQ)Greater than15.317
Debt to Asset Ratio (MRQ)Less than10.294
Debt to Equity Ratio (MRQ)Less than10.417
Return on Equity (MRQ)Greater than0.15-0.075
Return on Assets (MRQ)Greater than0.05-0.053
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Polynovo Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5069.787
Ma 20Greater thanMa 501.962
Ma 50Greater thanMa 1001.777
Ma 100Greater thanMa 2001.550
OpenGreater thanClose2.020
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets92,621
Total Liabilities27,238
Total Stockholder Equity65,383
 As reported
Total Liabilities 27,238
Total Stockholder Equity+ 65,383
Total Assets = 92,621

Assets

Total Assets92,621
Total Current Assets67,354
Long-term Assets25,266
Total Current Assets
Cash And Cash Equivalents 46,847
Short-term Investments 50
Net Receivables 13,693
Inventory 4,530
Other Current Assets 307
Total Current Assets  (as reported)67,354
Total Current Assets  (calculated)65,427
+/- 1,927
Long-term Assets
Property Plant Equipment 23,368
Long Term Investments 559
Intangible Assets 1,157
Long-term Assets Other 183
Long-term Assets  (as reported)25,266
Long-term Assets  (calculated)25,266
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,667
Long-term Liabilities14,570
Total Stockholder Equity65,383
Total Current Liabilities
Short-term Debt 1,890
Short Long Term Debt 1,398
Accounts payable 2,738
Other Current Liabilities 9,929
Total Current Liabilities  (as reported)12,667
Total Current Liabilities  (calculated)15,956
+/- 3,288
Long-term Liabilities
Long term Debt Total 14,154
Other Liabilities 417
Deferred Long Term Liability 183
Long-term Liabilities  (as reported)14,570
Long-term Liabilities  (calculated)14,753
+/- 183
Total Stockholder Equity
Common Stock191,591
Retained Earnings -121,378
Accumulated Other Comprehensive Income -4,830
Total Stockholder Equity (as reported)65,383
Total Stockholder Equity (calculated)65,383
+/-0
Other
Capital Stock191,591
Cash and Short Term Investments 46,897
Common Stock Shares Outstanding 684,454
Current Deferred Revenue-1,890
Liabilities and Stockholders Equity 92,621
Net Debt -30,803
Net Invested Capital 68,570
Net Tangible Assets 64,227
Net Working Capital 54,687
Property Plant and Equipment Gross 31,173
Short Long Term Debt Total 16,044



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-30
> Total Assets 
7,078
11,962
7,223
12,614
7,474
18,651
18,686
24,949
22,017
17,163
17,288
15,021
11,771
8,909
8,619
9,414
8,126
16,025
12,056
29,822
28,229
37,857
38,339
34,972
92,621
92,62134,97238,33937,85728,22929,82212,05616,0258,1269,4148,6198,90911,77115,02117,28817,16322,01724,94918,68618,6517,47412,6147,22311,9627,078
   > Total Current Assets 
5,568
10,447
5,684
12,317
7,188
17,682
17,357
23,748
20,978
16,732
12,704
6,336
7,648
4,935
4,775
5,735
4,382
12,392
7,959
26,125
19,902
19,278
16,244
16,190
67,354
67,35416,19016,24419,27819,90226,1257,95912,3924,3825,7354,7754,9357,6486,33612,70416,73220,97823,74817,35717,6827,18812,3175,68410,4475,568
       Cash And Cash Equivalents 
5,425
3
5,621
12,090
6,865
17,359
17,089
23,316
20,592
16,473
12,236
5,983
3,456
3,008
2,784
4,666
3,460
10,747
5,982
3,147
13,921
11,648
7,689
6,102
46,847
46,8476,1027,68911,64813,9213,1475,98210,7473,4604,6662,7843,0083,4565,98312,23616,47320,59223,31617,08917,3596,86512,0905,62135,425
       Short-term Investments 
0
10,360
0
0
0
0
0
0
0
0
0
60
3,760
1,860
1,160
60
60
50
50
19,050
50
50
50
50
50
505050505019,050505060601,1601,8603,7606000000000010,3600
       Net Receivables 
142
44
45
82
26
125
75
342
240
167
261
81
228
67
831
997
851
1,556
884
2,680
3,963
3,139
5,667
6,089
13,693
13,6936,0895,6673,1393,9632,6808841,55685199783167228812611672403427512526824544142
       Other Current Assets 
0
40
17
146
297
198
193
89
145
92
207
211
204
0
0
12
11
39
62
19,215
492
783
146
146
307
30714614678349219,2156239111200204211207921458919319829714617400
   > Long-term Assets 
1,510
1,515
1,539
297
286
969
1,329
1,201
1,039
431
4,584
8,686
4,124
3,974
3,844
3,679
3,743
3,633
4,097
3,697
8,327
18,579
22,095
18,782
25,266
25,26618,78222,09518,5798,3273,6974,0973,6333,7433,6793,8443,9744,1248,6864,5844311,0391,2011,3299692862971,5391,5151,510
       Property Plant Equipment 
10
15
39
297
286
969
829
713
552
293
1,834
1,677
1,471
1,292
1,089
950
1,008
993
1,452
1,140
6,008
16,537
19,823
16,752
23,368
23,36816,75219,82316,5376,0081,1401,4529931,0089501,0891,2921,4711,6771,834293552713829969286297391510
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103
99
121
124
161
171
142
144
297
559
55929714414217116112412199103000000000000000
       Intangible Assets 
1,500
1,500
1,500
0
0
0
0
0
0
0
2,520
2,520
2,520
2,520
2,520
2,520
2,520
2,520
2,520
2,396
2,148
1,900
1,652
1,404
1,157
1,1571,4041,6521,9002,1482,3962,5202,5202,5202,5202,5202,5202,5202,5202,52000000001,5001,5001,500
       Other Assets 
0
0
0
0
0
0
0
0
0
0
200
107
117
136
149
107
117
121
124
161
171
142
620
626
742
7426266201421711611241211171071491361171072000000000000
> Total Liabilities 
423
504
815
466
1,213
1,967
1,404
2,184
1,229
702
1,465
1,280
1,131
920
801
746
732
913
1,243
1,363
2,129
14,045
15,987
17,256
27,238
27,23817,25615,98714,0452,1291,3631,2439137327468019201,1311,2801,4657021,2292,1841,4041,9671,213466815504423
   > Total Current Liabilities 
414
504
815
466
1,199
1,934
1,370
2,090
1,173
682
683
912
893
575
515
495
489
706
1,070
1,218
2,064
9,475
8,650
7,756
12,667
12,6677,7568,6509,4752,0641,2181,0707064894955155758939126836821,1732,0901,3701,9341,199466815504414
       Short-term Debt 
0
10,360
0
0
0
0
0
0
0
0
0
60
3,760
1,860
1,160
60
60
50
50
0
5,628
5,628
2,875
1,788
1,890
1,8901,7882,8755,6285,6280505060601,1601,8603,7606000000000010,3600
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,304
2,525
1,330
1,398
1,3981,3302,5255,304000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
1,948
950
92
413
412
426
416
264
209
133
406
421
223
582
1,612
1,814
1,871
2,738
2,7381,8711,8141,612582223421406133209264416426412413929501,9480000000
       Other Current Liabilities 
-5
-9,856
30
96
43
1,934
174
142
223
590
270
459
466
160
252
285
356
300
648
995
1,482
7,863
6,835
5,932
9,929
9,9295,9326,8357,8631,4829956483003562852521604664592705902231421741,934439630-9,856-5
   > Long-term Liabilities 
9
0
0
0
15
33
35
94
56
20
782
367
238
345
285
251
243
207
173
145
65
4,570
7,338
9,500
14,570
14,5709,5007,3384,570651451732072432512853452383677822056943533150009
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,404
7,122
9,207
14,154
14,1549,2077,1224,404000000000000000000000
       Other Liabilities 
0
0
0
0
15
33
35
94
56
20
26
30
38
273
285
251
243
207
173
145
65
167
216
293
417
417293216167651451732072432512852733830262056943533150000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
476
329
183
1833294760000000000000000000000
> Total Stockholder Equity
6,655
11,458
6,408
12,149
6,261
16,685
17,282
22,765
20,788
16,461
14,589
13,751
10,677
8,028
7,863
8,718
7,555
15,112
10,813
28,459
26,099
23,812
22,352
17,715
65,383
65,38317,71522,35223,81226,09928,45910,81315,1127,5558,7187,8638,02810,67713,75114,58916,46120,78822,76517,28216,6856,26112,1496,40811,4586,655
   Common Stock
8,009
16,376
16,396
27,868
30,551
50,416
61,778
78,244
89,081
89,081
89,081
90,359
90,359
90,359
91,581
94,870
94,870
114,100
114,476
138,121
139,071
139,071
139,251
139,431
191,591
191,591139,431139,251139,071139,071138,121114,476114,10094,87094,87091,58190,35990,35990,35989,08189,08189,08178,24461,77850,41630,55127,86816,39616,3768,009
   Retained Earnings -121,378-116,454-115,261-110,656-106,459-103,269-97,295-92,289-89,227-87,925-84,988-83,496-80,796-77,879-76,018-74,188-69,746-56,339-44,880-34,115-24,572-16,002-10,270-5,199-1,636
   Accumulated Other Comprehensive Income 
-2
-6
-15
-53
282
383
383
860
1,453
1,567
1,525
1,272
1,115
1,166
1,270
1,773
1,913
-6,699
-6,368
-6,392
-6,512
-4,602
-1,637
-5,262
-4,830
-4,830-5,262-1,637-4,602-6,512-6,392-6,368-6,6991,9131,7731,2701,1661,1151,2721,5251,5671,453860383383282-53-15-6-2
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
284
288
297
335
0
0
0
0
0
0
0
0
0
0
0
1,773
1,913
-6,699
-6,368
-6,392
-6,512
-28,414
-23,989
-22,977
-70,213
-70,213-22,977-23,989-28,414-6,512-6,392-6,368-6,6991,9131,77300000000000335297288284



Balance Sheet

Currency in AUD. All numbers in thousands.